Hemodialysis patients. Care involving dialysis
Conditions
Interventions
Intervention 1: Control group: Patients in the control group will be received usual care. Intervention 2: Experimental group: experimental group will be exposed to the inhalation of lavender essence
Treatment - Drugs
Control group: Patients in the control group will be received usual care.
Experimental group: experimental group will be exposed to the inhalation of lavender essence produced by Barij certified pharmaceutical company with quality standards of ISO 9001 and ISO / IEC 17025 a
Sponsors
Vice Chancellor for research Mazandaran University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient including major criteria: at least 6 months of dialysis treatment; dialysis for 3 times a week; being over 18 years; alertness and ability to communicate; having a good sense of smell; have not a stressful event in the past 6 months; don't using sedatives drugs Patient eligibility major criteria: candidate for a transplant; pregnancy or decision to pregnancy; record of allergies; chronic respiratory diseases; addiction
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression and anxiety. Timepoint: Before intervention, Second and fourth weeks after intervention. Method of measurement: Hospital Anxiety and Depression Scale.;Fatigue. Timepoint: Before intervention, Second and fourth weeks after intervention. Method of measurement: Fatigue Severity Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Allergic to Lavender. Timepoint: To 4 weaks after the first intervention. Method of measurement: Side effects of the drug and the patient's questions. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAttieh Nikkhah
Mazandaran University of Medical Sciences
Outcome results
None listed